Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26FGW1F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,965
Award facts
- Contract value 100% obligated
- $22,965.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order carrying a $22,965.47 ceiling value to Amerisourcebergen Drug Corp on July 27, 2026, for DUPIXENT 300 MG/2 ML syringe 2ML (item 4572500962). The order is firm fixed-price, with an ultimate completion date of July 28, 2026, and place of performance in Conshohocken, PA 19428. It was issued with no set-aside. The prime holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26FGW1F?
SPE2DR26FGW1F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 27, 2026.
How much is contract SPE2DR26FGW1F worth?
The government has obligated $22,965 on SPE2DR26FGW1F.
Is contract SPE2DR26FGW1F an order under another contract?
Yes. SPE2DR26FGW1F is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGW1F competed?
The extent of competition for SPE2DR26FGW1F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award